In some cases, physical therapy and surgery are needed. However, arthritis management often involves medication. A common option that’s used to primarily alleviate mild joint pain and stiffness ...

In December, the U.S. Food and Drug Administration (FDA) approved a new treatment for people with insomnia, Dayvigo (lemborexant). The drug will be available in 5 or 10 milligram (mg) doses ...

But that doesn’t always make it easy to choose one that’s right for you. For example, some stronger medications target multiple symptoms, while others simply relieve a stuffy nose caused by ...

Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...

The regulator has set a timeframe of 12th August for its review of the new drug application (NDA) and – if approved – brensocatib could become a much-needed treatment option for hundreds of ...